These findings indicate that ARNTL2 promotes NPC lymphatic and pulmonary metastasis, along with tumor growth, by the inhibition of AMOTL2 and LATS-dependent YAP phosphorylation in vivo. Here, AMOTL2 is linked to nasopharyngeal carcinoma.